Literature DB >> 24990658

Addressing the burden of neonatal hyperbilirubinaemia in countries with significant glucose-6-phosphate dehydrogenase deficiency.

Bolajoko O Olusanya1, Abieyuwa A Emokpae2, Tara G Zamora3, Tina M Slusher4.   

Abstract

UNLABELLED: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an established worldwide risk factor for severe hyperbilirubinaemia. This literature review examined the pattern and management of severe hyperbilirubinaemia in low- and middle-income countries (LMICs) where G6PD deficiency was 10% or more and found that it was frequently associated with neonatal mortality and, or, neurodevelopmental disorders.
CONCLUSION: Low- and middle-income countries need to pay urgent attention to G6PD deficiency to curtail the preventable burden of jaundice-related morbidity, mortality and disability. ©2014 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Acute bilirubin encephalopathy; Child disability; Developing countries; Kernicterus; Phototherapy

Mesh：

Year:  2014        PMID： 24990658     DOI： 10.1111/apa.12735

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN： 0803-5253            Impact factor:   2.299


  21 in total

Review 1.  Parental education and the WHO neonatal G-6-PD screening program: a quarter century later.

Authors:  M Kaplan; C Hammerman; V K Bhutani
Journal:  J Perinatol       Date:  2015-07-16       Impact factor: 2.521

2.  A neurologic dysfunction scoring protocol for jaundiced neonates requiring exchange transfusion.

Authors:  Bolajoko O Olusanya; Folashade B Osibanjo; Adeniyi A Ajiboye; Oluwafemi E Ayodele; Adebanke A Odunsi; Serah M Olaifa; Abieyuwa A Emokpae
Journal:  J Matern Fetal Neonatal Med       Date:  2017-03-20

3.  Current Trends in Neonatal Morbidity and Mortality: Experiences from a Tertiary Center in Lagos, Nigeria.

Authors:  Iretiola Bamikeolu Fajolu; Katherine Megan Satrom; Beatrice Nkolika Ezenwa; Angela Christine Kein; Tina Marye Slusher; Veronica Chinyere Ezeaka
Journal:  Am J Trop Med Hyg       Date:  2022-07-25       Impact factor: 3.707

4.  Development of a mobile phone camera-based transcutaneous bilirubinometer for low-resource settings.

Authors:  Brandon Harrison-Smith; Alexander P Dumont; Mohammed Shahriar Arefin; Yu Sun; Nuradeen Lawal; Dorianna Dobson; Amy Nwaba; Sarah Grossarth; Abdulsalam Muhammed Paed; Zubaida L Farouk; Jorn-Hendrik Weitkamp; Chetan A Patil
Journal:  Biomed Opt Express       Date:  2022-04-15       Impact factor: 3.562

5.  Point-of-Care Quantitative Measure of Glucose-6-Phosphate Dehydrogenase Enzyme Deficiency.

Authors:  Vinod K Bhutani; Michael Kaplan; Bertil Glader; Michael Cotten; Jairus Kleinert; Vamsee Pamula
Journal:  Pediatrics       Date:  2015-10-12       Impact factor: 7.124

Review 6.  Infants at risk of significant hyperbilirubinemia in poorly-resourced countries: evidence from a scoping review.

Authors:  Bolajoko O Olusanya; Tina M Slusher
Journal:  World J Pediatr       Date:  2015-10-11       Impact factor: 2.764

7.  Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings.

Authors:  Bolajoko O Olusanya; Tinuade A Ogunlesi; Praveen Kumar; Nem-Yun Boo; Iman F Iskander; Maria Fernanda B de Almeida; Yvonne E Vaucher; Tina M Slusher
Journal:  BMC Pediatr       Date:  2015-04-12       Impact factor: 2.125

8.  Genetic polymorphisms in paraoxonase 1 and G protein-coupled receptor 77, and the risk of glucose-6-phosphate dehydrogenase deficiency in a Saudi population.

Authors:  Khalid K Alharbi
Journal:  Saudi Med J       Date:  2015-05       Impact factor: 1.484

Review 9.  Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysis.

Authors:  Bolajoko O Olusanya; Folasade B Osibanjo; Tina M Slusher
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240

10.  Heliotherapy for Neonatal Hyperbilirubinemia in Southwest, Nigeria: A Baseline Pre-Intervention Study.

Authors:  Abieyuwa A Emokpae; Cecilia A Mabogunje; Zainab O Imam; Bolajoko O Olusanya
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.